Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2010, Article ID 731202, 8 pages
http://dx.doi.org/10.1155/2010/731202
Research Article

Structurally Diverse Metal Coordination Compounds, Bearing Imidodiphosphinate and Diphosphinoamine Ligands, as Potential Inhibitors of the Platelet Activating Factor

1Biochemistry Laboratory, Faculty of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece
2Inorganic Chemistry Laboratory, Faculty of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece

Received 15 March 2010; Accepted 3 May 2010

Academic Editor: Spyros Perlepes

Copyright © 2010 Alexandros B. Tsoupras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Silvestru and J. E. Drake, “Tetraorganodichalcogenoimidodiphosphorus acids and their main group metal derivatives,” Coordination Chemistry Reviews, vol. 223, no. 1, pp. 117–216, 2001. View at Google Scholar · View at Scopus
  2. I. Haiduc, “Dichalcogenoimidodiphosphinato ligands,” in Comprehensive Coordination Chemistry II: From Biology to Nanotechnology, vol. 1, pp. 323–347, Elsevier, Amsterdam, The Netherlands, 2003. View at Google Scholar
  3. T. Chivers, J. Konu, J. S. Ritch, M. C. Copsey, D. J. Eisler, and H. M. Tuononen, “New tellurium-containing ring systems,” Journal of Organometallic Chemistry, vol. 692, no. 13, pp. 2658–2668, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Levesanos, S. D. Robertson, D. Maganas et al., “Ni[(EPiPr2)2N]2 complexes: stereoisomers (E=Se) and square-planar coordination (E=Te),” Inorganic Chemistry, vol. 47, no. 8, pp. 2949–2951, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Simón-Manso, M. Valderrama, and D. Boys, “Synthesis and single-crystal characterization of the square planar complex [Ni{(SPPh2)2N-S,S}2]·2THF,” Inorganic Chemistry, vol. 40, no. 14, pp. 3647–3649, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Rösler, C. Silvestru, G. Espinosa-Pérez, I. Haiduc, and R. Cea-Olivares, “Tetrahedral versus square-planar NiS4 core in solid-state bis(dithioimidodiphosphinato)nickel(II) chelates. Crystal and molecular structures of Ni[(SPR2)(SPPh2)N]2(R=Ph,Me),” Inorganica Chimica Acta, vol. 241, no. 2, pp. 47–54, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Maganas, A. Grigoropoulos, and S. S. Staniland, “Tetrahedral and square-planar Ni[(SPR2)2N]2 complexes, R=Ph&Pir revisited: experimental and theoretical analysis of interconversion pathways, structural preferences and spin delocalization,” Inorganic Chemistry, vol. 49, no. 11, pp. 5079–5093, 2010. View at Google Scholar
  8. T. Q. Ly and J. D. Woollins, “Bidentate organophosphorus ligands formed via P-N bond formation: synthesis and coordination chemistry,” Coordination Chemistry Reviews, vol. 176, no. 1, pp. 451–481, 1998. View at Google Scholar · View at Scopus
  9. E. I. Solomon, R. K. Szilagyi, S. DeBeer George, and L. Basumallick, “Electronic structures of metal sites in proteins and models: contributions to function in blue copper proteins,” Chemical Reviews, vol. 104, no. 2, pp. 419–458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Demopoulos, R. N. Pinckard, and D. J. Hanahan, “Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators),” Journal of Biological Chemistry, vol. 254, no. 19, pp. 9355–9358, 1979. View at Google Scholar · View at Scopus
  11. G. A. Zimmerman, T. M. McIntyre, S. M. Prescott, and D. M. Stafforini, “The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis,” Critical Care Medicine, vol. 30, no. 5, pp. S294–S301, 2002. View at Google Scholar · View at Scopus
  12. D. M. Stafforini, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott, “Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes,” Critical Reviews in Clinical Laboratory Sciences, vol. 40, no. 6, pp. 643–672, 2003. View at Google Scholar · View at Scopus
  13. G. Montrucchio, G. Alloatti, and G. Camussi, “Role of platelet-activating factor in cardiovascular pathophysiology,” Physiological Reviews, vol. 80, no. 4, pp. 1669–1699, 2000. View at Google Scholar · View at Scopus
  14. C. A. Demopoulos, H. C. Karantonis, and S. Antonopoulou, “Platelet activating factor—a molecular link between atherosclerosis theories,” European Journal of Lipid Science and Technology, vol. 105, no. 11, pp. 705–716, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. López-Novoa, “Potential role of platelet activating factor in acute renal failure,” Kidney International, vol. 55, no. 5, pp. 1672–1682, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. L. M. McManus and R. N. Pinckard, “PAF, a putative mediator of oral inflammation,” Critical Reviews in Oral Biology and Medicine, vol. 11, no. 2, pp. 240–258, 2000. View at Google Scholar · View at Scopus
  17. A. Kasperska-Zajac, Z. Brzoza, and B. Rogala, “Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy,” Recent Patents on Inflammation and Allergy Drug Discovery, vol. 2, no. 1, pp. 72–76, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Nathan, Y. Denizot, M. C. Huc et al., “Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus,” Diabete & Metabolisme, vol. 18, no. 1, pp. 59–62, 1992. View at Google Scholar · View at Scopus
  19. A. B. Tsoupras, C. Iatrou, C. Frangia, and C. A. Demopoulos, “The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants,” Infectious Disorders—Drug Targets, vol. 9, no. 4, pp. 390–399, 2009. View at Google Scholar · View at Scopus
  20. A. B. Tsoupras, M. Chini, N. Tsogas et al., “Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?” AIDS Research and Human Retroviruses, vol. 24, no. 8, pp. 1079–1086, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Negro Álvarez, J. C. Miralles López, J. L. Ortiz Martínez, A. Abellán Alemán A, and R. Rubio Del Barrio, “Platelet-activating factor antagonists,” Allergologia et Immunopathologia, vol. 25, no. 5, pp. 249–258, 1997. View at Google Scholar · View at Scopus
  22. S. Desquand, “Effects of PAF antagonists in experimental models—possible therapeutic implications,” Therapie, vol. 48, no. 6, pp. 585–597, 1993. View at Google Scholar · View at Scopus
  23. M. Koltai, D. Hosford, P. Guinot, A. Esanu, and P. Braquet, “Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications. I.,” Drugs, vol. 42, no. 1, pp. 9–29, 1991. View at Google Scholar · View at Scopus
  24. M. Koltai, D. Hosford, P. Guinot, A. Esanu, and P. Braquet, “PAF: a review of its effects, antagonists and possible future clinical implications. II.,” Drugs, vol. 42, no. 2, pp. 174–204, 1991. View at Google Scholar · View at Scopus
  25. C. X. Zhang and S. J. Lippard, “New metal complexes as potential therapeutics,” Current Opinion in Chemical Biology, vol. 7, no. 4, pp. 481–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. H. van Rijt and P. J. Sadler, “Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs,” Drug Discovery Today, vol. 14, pp. 1089–1197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Timerbaev, “Advances in developing tris(8-quinolinolato)gallium(III) as an anticancer drug: critical appraisal and prospects,” Metallomics, vol. 1, pp. 193–198, 2009. View at Google Scholar
  28. M. A. Jakupec and B. K. Keppler, “Gallium in cancer treatment,” Current Topics in Medicinal Chemistry, vol. 4, no. 15, pp. 1575–1583, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Marzano, M. Pellei, F. Tisato, and C. Santini, “Copper complexes as anticancer agents,” Anti-Cancer Agents in Medicinal Chemistry, vol. 9, no. 2, pp. 185–211, 2009. View at Google Scholar · View at Scopus
  30. Z. H. Chohan, “Metal-based antibacterial and antifungal sulfonamides: synthesis, characterization, and biological properties,” Transition Metal Chemistry, vol. 34, no. 2, pp. 153–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Sakurai, A. Katoh, and Y. Yoshikawa, “Chemistry and biochemistry of insulin-mimetic vanadium and zinc complexes. Trial for treatment of diabetes mellitus,” Bulletin of the Chemical Society of Japan, vol. 79, no. 11, pp. 1645–1664, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. R. P. Kamalesh Babu, S. S. Krishnamurthy, and M. Nethaji, “Short-bite chiral diphosphazanes derived from (S)-α-methyl benzyl amine and their Pd, Pt and Rh metal complexes,” Tetrahedron Asymmetry, vol. 6, no. 2, pp. 427–438, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Silvestru, A. Rotar, J. E. Drake et al., “Synthesis, spectroscopic characterization, and structural studies of new Cu(I) and Cu(II) complexes containing organophosphorus ligands, and crystal structures of (Ph3P)2Cu[S2PMe2], (Ph3P)2Cu[(OPPh2)2N], Cu[(OPPh2)2N]2, and Cu[(OPPh2)(SPPh2)N]2,” Canadian Journal of Chemistry, vol. 79, pp. 983–991, 2001. View at Google Scholar
  34. A. Silvestru, D. Ban, and J. E. Drake, “Zinc(II) tetraorganodichalcogenoimidodiphosphinates. Crystal and molecular structure of Zn[(OPPh2)2N]2,” Revue Roumaine de Chimie, vol. 47, no. 10-11, pp. 1077–1084, 2002. View at Google Scholar · View at Scopus
  35. A. Davison and E. S. Switkes, “The stereochemistry of four-coordinate bis(imidodiphosphinato)metal(II) chelate complexes,” Inorganic Chemistry, vol. 10, no. 4, pp. 837–842, 1971. View at Google Scholar · View at Scopus
  36. V. García-Montalvo, R. Cea-Olivares, D. J. Williams, and G. Espinosa-Pérez, “Stereochemical consequences of the bismuth atom electron lone pair, a comparison between MX6E and MX6 systems. Crystal and molecular structures of tris[N-(P,P-diphenylphosphinoyl)-P,P-diphenylphosphinimidato]bismuth(III),[[Bi{(OPPh2)2N}3], -indium(III),[In{(OPPh2)2N}3]·C6H6, and -gallium(III), [Ga{(OPPh2)2N}3]·CH2Cl2,” Inorganic Chemistry, vol. 35, no. 13, pp. 3948–3953, 1996. View at Google Scholar · View at Scopus
  37. G. C. Vougioukalakis, I. Stamatopoulos, N. Petzetakis et al., “Controlled vinyl-type polymerization of norbornene with a nickel(II) diphosphinoamine/methylaluminoxane catalytic system,” Journal of Polymer Science A, vol. 47, no. 20, pp. 5241–5250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. F. T. Wang, J. Najdzionek, K. L. Leneker, H. Wasserman, and D. M. Braitsch, “Facile synthesis of imidotetraphenyldiphosphinic acids,” Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry, vol. 8, pp. 119–125, 1978. View at Google Scholar
  39. M. Lazanas, C. A. Demopoulos, S. Tournis, S. Koussissis, K. Labrakis-Lazanas, and X. Tsarouhas, “PAF of biological fluids in disease: I.V. Levels in blood in allergic reactions induced by drugs,” Archives of Dermatological Research, vol. 280, no. 2, pp. 124–126, 1988. View at Google Scholar · View at Scopus
  40. D. Tsoukatos, C. A. Demopoulos, A. D. Tselepis et al., “Inhibition of cardiolipins of platelet-activating factor-induced rabbit platelet activation,” Lipids, vol. 28, no. 12, pp. 1119–1124, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Noth, “Crystal and molecular-structure of imido-tetraphenyl-dithio-phosphinic acid and imido-tetraphenyl-diphosphinic acid,” Zeitschrift für Naturforschung B, vol. 37, pp. 1491–1498, 1982. View at Google Scholar
  42. A. I. Philippopoulos, N. Tsantila, C. A. Demopoulos, C. P. Raptopoulou, V. Likodimos, and P. Falaras, “Synthesis, characterization and crystal structure of the cis-[RhL2Cl2]Cl complex with the bifunctional ligand (L) 2-(2-pyridyl)quinoxaline. Biological activity towards PAF (Platelet Activating Factor) induced platelet aggregation,” Polyhedron, vol. 28, no. 15, pp. 3310–3316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. H. O. Heuer, “Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists,” Lipids, vol. 26, no. 12, pp. 1369–1373, 1991. View at Google Scholar · View at Scopus
  44. J. R. Fletcher, A. G. DiSimone, and M. A. Earnest, “Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia,” Annals of Surgery, vol. 211, no. 3, pp. 312–316, 1990. View at Google Scholar · View at Scopus
  45. I. Izquierdo, M. Merlos, and J. García-Rafanell, “Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis,” Drugs of Today, vol. 39, no. 6, pp. 451–468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Huo, J. Ekholm, and D. J. Hanahan, “A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets,” Archives of Biochemistry and Biophysics, vol. 260, no. 2, pp. 841–846, 1988. View at Google Scholar · View at Scopus
  47. I. B. Afanas'ev, E. A. Ostrakhovitch, E. V. Mikhal'chik, G. A. Ibragimova, and L. G. Korkina, “Enhancement of antioxidant and anti-inflammatory activities of bioflavonoid rutin by complexation with transition metals,” Biochemical Pharmacology, vol. 61, no. 6, pp. 677–684, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. C. T. Dillon, T. W. Hambley, B. J. Kennedy et al., “Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinfiammatory drug indomethacin,” Chemical Research in Toxicology, vol. 16, no. 1, pp. 28–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Kovala-Demertzi, D. Hadjipavlou-Litina, M. Staninska, A. Primikiri, C. Kotoglou, and M. A. Demertzis, “Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II),” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 24, no. 3, pp. 742–752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Mohan, R. Nagar, S. C. Agarwal, KM. A. Mehta, and C. S. Rao, “Syntheses and anti-inflammatory activity of diphenylamine-2,2-dicarboxylic acid and its metal complexes,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 20, no. 1, pp. 55–60, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. R. M. S. Pereira, N. E. D. Andrades, N. Paulino et al., “Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity,” Molecules, vol. 12, no. 7, pp. 1352–1366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Pontiki, D. Hadjipavlou-Litina, and A. T. Chaviara, “Evaluation of anti-inflammatory and antioxidant activities of copper (II) Schiff mono-base and copper(II) Schiff base coordination compounds of dien with heterocyclic aldehydes and 2-amino-5-methyl-thiazole,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 23, no. 6, pp. 1011–1017, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. V. O. Melnikova, K. Balasubramanian, G. J. Villares et al., “Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis,” Journal of Biological Chemistry, vol. 284, no. 42, pp. 28845–28855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. V. O. Melnikova and M. Bar-Eli, “Inflammation and melanoma metastasis,” Pigment Cell and Melanoma Research, vol. 22, no. 3, pp. 257–267, 2009. View at Publisher · View at Google Scholar · View at Scopus